Together, these results could aid in further underlying mechanism studies of C9-HRE-related C9ALS/FTD and pathological regulation in both DNA and RNA levels related to C9-HRE loss-of-function and gain-of-function toxicity. The gene discussed is C9; the disease is frontotemporal dementia.